EUDAMED Is Now Mandatory. The Bigger Story Is What It Reveals About Multilingual Compliance Risk

As medical device compliance becomes increasingly digital and transparent, manufacturers must rethink how they manage multilingual regulatory information.

As of 28 May 2026, the first four EUDAMED modules became mandatory under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR).

For many organizations, this milestone represents another regulatory deadline in a long list of MDR and IVDR requirements. But focusing only on the deadline risks missing the bigger story.

The mandatory rollout of EUDAMED is not simply about registering information in a new system. It reflects a broader shift toward transparency, traceability, and interconnected regulatory data.

And for medical device manufacturers, it raises an important question: Is your multilingual regulatory information as compliant and consistent as the devices it describes?

EUDAMED does not create new translation obligations. It exposes weaknesses in how multilingual regulatory information is managed.

EUDAMED Is Not Just Another Regulatory Database

The first mandatory EUDAMED modules include Actor Registration, UDI/Device Registration, Notified Bodies & Certificates, and Market Surveillance.

Together, these modules create a centralized ecosystem designed to improve transparency, coordination, and oversight across the European medical device market. As information becomes increasingly searchable, connected, and visible, expectations around data quality, consistency, and governance also increase.

The Shift From Document Compliance to Data Compliance

Historically, compliance was largely document-centric. Organizations focused on technical files, Instructions for Use (IFUs), certificates, labels, and submission packages.

Today, regulatory systems are becoming increasingly digital, interconnected, and data-driven. Instead of information existing only within standalone documents, it is increasingly structured, connected, searchable, and visible across systems.

For Regulatory Affairs, Quality, and Documentation teams, the challenge is no longer limited to maintaining compliant documents. It increasingly includes maintaining compliant information across systems, languages, and markets.

The Risk Is Not Translation. It Is Governance.

When multilingual compliance issues arise, translation is often blamed. In reality, translation errors are rarely the root cause. The greater risk is usually poor governance.

Terminology drift, translation update gaps, and fragmented ownership can create inconsistencies across documentation, labeling, registrations, and systems. EUDAMED does not create these challenges. It exposes them.

Example: When Translation Becomes a Governance Issue

A manufacturer updates a device description following a product modification.

The updated information is reflected in regulatory documentation and entered into EUDAMED. Some language versions are updated immediately. Others are updated weeks later.

No individual translation is technically incorrect.

Yet for a period of time, regulators, healthcare professionals, and internal teams may be referencing different versions of the same information.

The risk is not poor translation. The risk is inconsistent regulatory data.

Why EUDAMED Raises the Stakes

The mandatory rollout of EUDAMED does not introduce new translation requirements. What it introduces is greater visibility.

As information becomes more transparent and interconnected, organizations should begin thinking beyond individual translation projects and focus instead on multilingual information governance.

The question is no longer: 'Has this content been translated?'

The question is increasingly: 'Can we demonstrate that our information remains consistent across languages, systems, and regulatory processes?'

EUDAMED Readiness Checklist

• Do you have approved multilingual terminology for device names and key regulatory concepts?
• Can you demonstrate version control across all language variants?
• Are translation updates linked to formal change control processes?
• Are responsibilities clearly defined between Regulatory Affairs, Quality, Product, and language providers?
• Can you quickly identify which translations are currently approved and in use?
• Are your language partners experienced in medical device regulations and quality systems?
• Are you preparing now for future EUDAMED modules?

What Comes Next

Medical device compliance is becoming increasingly digital. Regulatory information is becoming increasingly interconnected. Transparency expectations continue to rise.

Organizations that establish strong multilingual governance processes today will be better positioned to adapt to future requirements and future EUDAMED modules.

Final Thoughts

EUDAMED is often described as a database. In reality, it is a signal.

A signal that medical device compliance is becoming increasingly transparent, interconnected, and data-driven.

The organizations that succeed in this environment will not simply translate content. They will build governance processes capable of maintaining consistency across systems, countries, languages, and regulatory requirements.

‍